Clarity Medical Group Holding Limited reported no changes to its share capital during August 2026. Authorised share capital remained at 5.00 billion ordinary shares with a par value of HKD 0.01, equivalent to HKD 50.00 million. Issued shares were steady at 539.77 million, and the company held no treasury shares.
Management confirmed compliance with the Hong Kong Stock Exchange’s minimum 25 percent public-float requirement as at 31 August 2026.
There were no share issuances, cancellations, repurchases, or transfers during the month. The Pre-IPO share option scheme had zero options outstanding or exercisable, and no new options were granted. Under the existing share award plan, the company may issue up to 40.54 million shares, but none were granted or vested in August.
The unchanged capital base combined with confirmed float sufficiency indicates that Clarity Medical’s equity structure remained stable throughout the reporting period, with no dilution to existing shareholders.
Comments